FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · FDA: PRESS ANNOUNCEMENTS · 20 October 2026

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

Synopsis

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women The generic estradiol and levonorgestrel transdermal system is therapeutically equivalent to Climara Pro, which is indicated for use in women with an intact uterus for:

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at FDA: press announcements ↗

More in New medicines and drug discovery